References
Castellino, F. J. 1979. A unique enzyme-protein substrate modified reaction: plasmin/streptokinase interaction. Trends in Biochemical Science 4, 1–5.
Cederholm-Williams, S. and Fennell, S. J. 1981. Binding of plasmin(ogen) to Sepharose bound fibrin(ogen) α chain. Thrombos. Res. 21, 503- 504.
Chesterman, C. N. 1978. Fibrinolysis and disseminated intravascular coagulation. In: Fibrinolysis: Current Fundamental and Clinical Concepts. Eds. P. J. Gaffney and S. Balkuv-Ulutin. Academic Press, London, pp. 157–172.
Collen, D. 1976. Identification and some properties of a new fast-acting plasmin inhibitor in human plasma. Eur. J. Biochem. 69, 209–216.
Conway, E. J. 1943. The chemical evolution of the ocean. Proc. Roy. Ir. Acad. 48B, 161.
Conway, E. J. 1957. Micro-diffusion analysis and volumetric error. Crosby Lockwood, London, 4th edit.
Conway, E. J., O’Connor, J. M. and O’Donovan, D. K. 1937. The influence of temperature on the activity of the kidney in relation to its influence on oxygen consumption. Proc. Roy. Ir. Acad. 44B, 1.
Conway, E. J., Fitzgerald, O. and McDougald, R. C. 1946. Potassium accumulation in the proximal tubule of the frog’s kidney. J. Gen. Physiol. 29, 305.
Flute, P. T. 1977. Disorders of plasma fibrinogen sylnthesis. Brit. med. Bull. 33, 253–259.
Gaffney, P. J. 1973. The molecular and functional condition of plasma fibrinogen during thrombolytic therapy with streptokinase (SK). Thrombos. Res. 2, 105–114.
Gaffney, P. J. 1975. Distinction between fibrinogen and fibrin degradation products in plasma. Clin. Chim. Acta 65, 109–115.
Gaffney, P. J. 1977. Structure of fibrinogen and degradation products of fibrinogen and fibrin. Brit. med. Bull. 33, 245–252.
Gaffney, P. J. 1981. The fibrinolytic system. In: Haemostasis and Thrombosis. Eds. A. L. Bloom and D. P. Thomas. Churchill Livingstone, Edinburgh, pp. 198–224.
Gaffney, P. J. 1983. The occurrence and clinical relevance of fibrin fragments in blood. Ann N.Y. Acad. Sci. 408, 407–423.
Gaffney, P. J., Chesterman, C. N. and Allington, M. J. 1974. Plasma fibrinogen and its fragments during streptokinase treatment. Brit. J. Haematol. 26, 285–293.
Gaffney, P. J. and Dobos, P. 1971. A structural aspect of human fibrinogen suggested by its plasmin degradation. FEBS Lett. 15, 13–16.
Gaffney, P. J. and Whitaker, A. N. 1979. Fibrin crosslinks and lysis rates. Thrombos. Res. 14, 85–94.
Graeff, H. and Hafter, R. 1982. Detection and relevance of crosslinked fibrin derivatives in blood. Sem. Thrombos. Haemos. 8, 57–68.
Holt, J., Mahmoud, M. and Gaffney, P. J. 1979. The ability of fibrinogen and its degradation products to support ADP-induced platelet aggregation. Thrombos. Res. 16, 427–435.
Iwanaga, S., Suzuki, K. and Hashimoto, S. 1978. Bovine plasma cold-insoluble globulin. Gross structure and function. Ann. N.Y. Acad. Sci. 312, 56–73.
Lijnen, H. R., Hoykaertsm, N. and Collen, D. 1980. Isolation and characterisation of a human plasma protein with affinity for the lysine-binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein. J. Biol. Chem. 255, 10214–10222.
Marder, V. J. and Shulman, N. R. 1969. High molecular weight plasma derivatives of human fibrinogen produced by plasmin. II: Mechanism of their anticoagulant activity. J. Biol. Chem. 244, 2120–2124.
Menaché, D. 1983. Congenital fibrinogen abnormalities. Ann. N.Y. Acad. Sci. 408, 121–130.
Mosher, D. 1975. Crosslinking of cold-insoluble globulin by fibrin stabilising factors. J. Biol. Chem. 250, 6614–6621.
Mullertz, S. and Clemmensen, I. 1976. The primary inhibitor of plasmin in blood. Biochemical J. 159, 545–553.
Olexa, S. A. and Budzynski, A. Z. 1980. Effects of fibrinopeptide cleavage on the plasmic degradation pathways of human cross-linked fibrin. Biochemistry 19, 647–651.
Pauling, L., Itano, H. A., Singer, S. J. and Wells, I. C. 1949. Sickle-cell anaemia, a molecular disease. Science 110, 543.
Rickli, E. E. 1975. The activation mechanism of human plasminogen. Throm. Diath. Haemorr. 34, 386–395.
Sakata, Y. and Aoki, N. 1980. Crosslinking of α2 plasmin inhibitor to fibrin by fibrin-stabilising factor. J. Clin. Invest. 65, 290–297.
Saldeen, T. 1983. Vasoactive peptides derived from degradation of fibrinogen and fibrin. In: Molecular Biology of Fibrinogen and Fibrin. Eds. M. W. Mosesson and R. F. Doolittle. Ann. N.Y. Acad. Sci., New Yirk, 408 424–437.
Tamaki, T. and Aoki, N. 1982. Crosslinking of α2- plasmin inhibitor to fibrin catalysed by activated stabilising factor. J. Biol. Chem. 257, 14767- 14772.
Whitaker, A. N., Rowe, E. A., Masci, P. and Gaffney, P. J. 1980. Identification of D dimer-E complex in disseminated intravascular coagulation (DIC). Throm. Res. 18, 453–459.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gaffney, P.J. Some aspects of the molecular pathology of thrombosis and haemorrhage. I.J.M.S. 153, 2–10 (1984). https://doi.org/10.1007/BF02940516
Issue Date:
DOI: https://doi.org/10.1007/BF02940516